US EditionHealth Will Begin Vaccination Against Respiratory Syncicial Virus in January 2026
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
The National Government informed the various jurisdictions that on 12 January 2026, the strategy for vaccination against the Respiratory Syncicial Virus (RSV) will be launched in order to anticipate health risks and protect newborns. The strategy is aimed at all women between weeks 32 and 36, as well as six days of pregnancy; no medical order is needed to receive it, and only the certificate indicating the week of pregnancy must be submitted. SR…
Buenos Aires, 13 December (NA) -- The Ministry of Health of the Nation reported that on January 12, 2026, the strategy of vaccination against the Respiratory Sincicial Virus (RSV) will begin throughout the country, with the aim of anticipating the circulation of the virus and guaranteeing the protection of newborns, according to the Argentine News Agency. The health portfolio communicated the decision by means of a circular sent to all jurisdict…
Canal C Prenatal vaccination against the VSR: protects from birth The Ministry of Health of the Nation today notified all jurisdictions that from January 12th they will have to start the application of the vaccine against the Respiratory Syncicial Virus (VSR).This dose, intended for pregnant women, allows babies to be born with immediate protection against respiratory infections and complications that usually result in hospitalizations during th…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
